CRISP2 and neoplasm: In breast cancer (BRCA), CRISP2 expression was significantly lower in tumor tissues compared to normal tissues (Figure 5A), with diagnostic efficacy indicated by a Receiver Operating Characteristic (ROC) curve showing an AUC of 0.706 (Figure 5B).